ArticleBiomarker insights2014

Utility of C-terminal Telopeptide in Evaluating Levothyroxine Replacement Therapy-Induced Bone Loss.

Alap L Christy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.